NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal second quarter revenues were down 3 percent year over year, reflecting the divestiture of its respiratory solutions business completed in October 2016. On a comparable, currency-neutral basis, Q2 revenues grew 5 percent, BD said.

For the three months ended March 31, BD posted revenues of $2.97 billion compared to $3.07 billion in the year-ago quarter, beating analysts' average estimate of $2.92 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.